Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

MR antagonists may improve skin health and wound healing, especially in aging.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

BMS-470539 reduces skin fibrosis and inflammation.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Minoxidil sulfate relaxes muscle by increasing potassium flow, making it a unique muscle relaxer.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Analog 23 is a promising compound for prostate cancer treatment.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.